An Exceedingly Rare Case of Liraglutide-Induced Liver Injury

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.

Detalles Bibliográficos
Autores principales: Parvataneni, Swetha, Ramachandran, Rajarajeshwari, Then, Eric, Grantham, Tyler, Gaduputi, Vinaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405313/
https://www.ncbi.nlm.nih.gov/pubmed/34471551
http://dx.doi.org/10.1155/2021/6306149
Descripción
Sumario:Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.

Ejemplares similares